News about Market

Eli Lilly India, Fortis Healthcare Mark World Alzheimer's Day

li Lilly India and Fortis Healthcare marked World Alzheimer’s Day by highlighting brain health, early signs of cognitive changes and timely medical guidance.

Market | 22/09/2026 | By News Bureau

EU Recommends Klygefa in AChR-Positive gMG

Alexion’s Klygefa (gefurulimab) receives a positive CHMP opinion for adults with AChR antibody-positive generalised myasthenia gravis in the EU.

Market | 21/09/2026 | By News Bureau

Takeda and Dr. Reddy's Partner to Sell QDENGA in India

Takeda and Dr. Reddy's Laboratories have entered into an exclusive collaboration to promote and distribute QDENGA in India's pediatric and adult private market.

Market | 19/09/2026 | By News Bureau

Merck Expands Jigani Facility to Boost Life Science Manufacturing

Merck has invested approximately Euro 13 million to expand its Jigani, Bengaluru facility with new biological buffer manufacturing capabilities.

Market | 18/09/2026 | By News Bureau |  176

Aethlon Medical to Merge with North Immunology in All-Stock Deal

Aethlon Medical and North Immunology plan to combine through an all-stock merger, backed by an approximately USD 180 million private placement to advance NOR-101 into clinical development.

Market | 18/09/2026 | By News Bureau

US FDA Finalises Expedited IND Pilot to Accelerate First-in-Human Clinical Trials

The US FDA has finalised the Expedited IND Pilot, which will test a rolling review model and greater coordination to support faster initiation of first-in-human clinical trials.

Market | 17/09/2026 | By News Bureau

Jazz Pharmaceuticals Acquires Actio Biosciences

Jazz Pharmaceuticals acquires ABS-1230, a first-in-class precision therapy for KCNT1-related epilepsy, strengthening its rare disease pipeline.

Market | 16/09/2026 | By News Bureau

GSK to Acquire Chimagen's Trispecific T-Cell Engager for Multiple Myeloma

GSK agrees to acquire global rights to Chimagen Biosciences’ investigational trispecific T-cell engager for multiple myeloma in a deal valued at up to USD 750 million.

Market | 16/09/2026 | By News Bureau |  101

Dr. Reddy's launches NIVORZ in India

Dr. Reddy’s has launched NIVORZ, a nivolumab biosimilar in India, marking its entry into biosimilar immuno-oncology with approval across 12 cancer indications.

Market | 16/09/2026 | By News Bureau

Alkem Launches NeuCeno (Cenobamate) Treatment of Partial-onset Seizures in Adult Patients

Alkem launches NeuCeno (cenobamate) in India for partial-onset seizures in adults, marking the first introduction of cenobamate in the country.

Market | 16/09/2026 | By News Bureau